SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy

R Ameratunga - Expert Review of Vaccines, 2022 - Taylor & Francis
Introduction COVID-19 has had a catastrophic impact on the world. The current death toll far
exceeds 6 million and large numbers of patients are experiencing long-term medical and …

Is SARS-CoV-2 the only cause of long-COVID?

I Pintos, V Moreno-Torres, F Ibánez-Estéllez… - 2022 - reunir.unir.net
Around 10% of adults infected with SARS-CoV-2 that survive a first episode of COVID-19
appear to experience long-term clinical manifestations. The signs and symptoms of this post …

[HTML][HTML] Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients

S Vasileiou, LQ Hill, M Kuvalekar, AG Workineh… - …, 2023 - ncbi.nlm.nih.gov
Defects in T-cell immunity to SARS-CoV-2 have been linked to an increased risk of severe
COVID-19 (even after vaccination), persistent viral shedding and the emergence of more …

SARS-CoV-2 omicron: Light at the end of the long pandemic tunnel or another false dawn for immunodeficient patients?

R Ameratunga, E Leung, ST Woon, L Chan… - The Journal of Allergy …, 2022 - Elsevier
COVID-19 has had a disastrous impact on the world. Apart from at least 6 million deaths,
countless COVID-19 survivors are suffering long-term physical and psychiatric morbidity …

Induction of pulmonary HLA-G expression by SARS-CoV-2 infection

B Seliger, S Jasinski-Bergner, C Massa… - Cellular and Molecular …, 2022 - Springer
The non-classical human leukocyte antigen (HLA)-G exerts immune-suppressive properties
modulating both NK and T cell responses. While it is physiologically expressed at the …

Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?

AZ Al Meslamani - Expert Review of Clinical Immunology, 2023 - Taylor & Francis
As of 26 July 2023, the SARS-CoV-2 virus has caused 768,560,727 confirmed cases of the
Coronavirus disease 2019 (COVID-19), and 6,952,522 fatalities worldwide [1]. Although the …

Selective IgA deficiency may be an underrecognized risk factor for severe COVID-19

R Ameratunga, E Leung, ST Woon, E Lea… - The Journal of Allergy …, 2023 - Elsevier
SARS-CoV-2, the agent responsible for COVID-19, has wreaked havoc around the globe.
Hundreds of millions of individuals have been infected and well over six million have died …

Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patients

R Ameratunga, ST Woon, R Steele, K Lehnert… - Journal of Clinical …, 2022 - jcp.bmj.com
After almost 3 years of intense study, the immunological basis of COVID-19 is better
understood. Patients who suffer severe disease have a chaotic, destructive immune …

SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 …

R Ameratunga, A Jordan, K Lehnert, E Leung… - Antiviral Research, 2024 - Elsevier
COVID-19 has caused calamitous health, economic and societal consequences. Although
several COVID-19 vaccines have received full authorization for use, global deployment has …

Effect of SARS-CoV2 infection on disease flares in patients with systemic lupus erythematosus: a case–control study

CC Mok, CCL Cheung, KL Chan, SM Tse… - Rheumatology, 2023 - academic.oup.com
Objectives To study the effect of SARS-CoV2 infection on flares of systemic lupus
erythematosus (SLE). Methods Patients who fulfilled the ACR/SLICC criteria for SLE and …